- Home
- ZVRA vs CPAC Comparison
ZVRA vs CPAC Comparison
Compare ZVRA & CPAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZVRA
- CPAC
- Stock Information
- Founded
- ZVRA 2006
- CPAC 1949
- Country
- ZVRA United States
- CPAC Peru
- Employees
- ZVRA N/A
- CPAC N/A
- Industry
- ZVRA Biotechnology: Pharmaceutical Preparations
- CPAC Building Materials
- Sector
- ZVRA Health Care
- CPAC Industrials
- Exchange
- ZVRA Nasdaq
- CPAC Nasdaq
- Market Cap
- ZVRA 511.6M
- CPAC 495.3M
- IPO Year
- ZVRA 2015
- CPAC 2012
- Fundamental
- Price
- ZVRA $8.49
- CPAC $5.56
- Analyst Decision
- ZVRA Strong Buy
- CPAC Sell
- Analyst Count
- ZVRA 7
- CPAC 1
- Target Price
- ZVRA $21.20
- CPAC $6.00
- AVG Volume (30 Days)
- ZVRA 550.1K
- CPAC 9.6K
- Earning Date
- ZVRA 11-12-2024
- CPAC 02-12-2025
- Dividend Yield
- ZVRA N/A
- CPAC 9.75%
- EPS Growth
- ZVRA N/A
- CPAC 7.38
- EPS
- ZVRA N/A
- CPAC 0.12
- Revenue
- ZVRA $24,489,000.00
- CPAC $527,798,215.00
- Revenue This Year
- ZVRA N/A
- CPAC N/A
- Revenue Next Year
- ZVRA $383.29
- CPAC N/A
- P/E Ratio
- ZVRA N/A
- CPAC $9.69
- Revenue Growth
- ZVRA 47.85
- CPAC N/A
- 52 Week Low
- ZVRA $4.20
- CPAC $4.95
- 52 Week High
- ZVRA $9.76
- CPAC $6.65
- Technical
- Relative Strength Index (RSI)
- ZVRA 44.11
- CPAC 35.31
- Support Level
- ZVRA $8.17
- CPAC $5.80
- Resistance Level
- ZVRA $8.73
- CPAC $6.10
- Average True Range (ATR)
- ZVRA 0.41
- CPAC 0.20
- MACD
- ZVRA -0.10
- CPAC -0.02
- Stochastic Oscillator
- ZVRA 21.77
- CPAC 20.59
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With unique, data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
About CPAC Cementos Pacasmayo S.A.A. (Each representing five)
Cementos Pacasmayo SAA is a Peruvian cement company that primarily produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are primarily used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.